Comparison between Entero Healthcare Solutions IPO and J.G.Chemicals IPO.
Entero Healthcare Solutions IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while J.G.Chemicals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Entero Healthcare Solutions IPO is up to ₹1,600.00 Cr whereas the issue size of the J.G.Chemicals IPO is up to ₹251.19 Cr. The final issue price of Entero Healthcare Solutions IPO is ₹1,258.00 per share and of J.G.Chemicals IPO is ₹221.00 per share.
| Entero Healthcare Solutions IPO | J.G.Chemicals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,195.00 per share | ₹210.00 per share |
| Issue Price (Upper) | ₹1,258.00 per share | ₹221.00 per share |
| Issue Price (Final) | ₹1,258.00 per share | ₹221.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹119.00 per share | |
| Market Lot Size | 11 shares | 67 shares |
| Fresh Issue Size | 79,52,518 shares | 74,66,063 shares |
| Fresh Issue Size (Amount) | up to ₹1,000.31 Cr | up to ₹165.00 Cr |
| OFS Issue Size | 47,67,526 shares | 39,00,000 shares |
| OFS Issue Size (Amount) | up to ₹599.69 Cr | up to ₹86.19 Cr |
| Issue Size Total | 1,27,20,044 shares | 1,13,66,063 shares |
| Issue Size Total (Amount) | up to ₹1,600.00 Cr | up to ₹251.19 Cr |
Entero Healthcare Solutions IPO opens on Feb 09, 2024, while J.G.Chemicals IPO opens on Mar 05, 2024. The closing date of Entero Healthcare Solutions IPO and J.G.Chemicals IPO is Feb 13, 2024, and Mar 07, 2024, respectively.
| Entero Healthcare Solutions IPO | J.G.Chemicals IPO | |
|---|---|---|
| Anchor Bid Date | Feb 08, 2024 | Mar 04, 2024 |
| Issue Open | Feb 09, 2024 | Mar 05, 2024 |
| Issue Close | Feb 13, 2024 | Mar 07, 2024 |
| Basis Of Allotment (Tentative) | Feb 14, 2024 | Mar 11, 2024 |
| Initiation of Refunds (Tentative) | Feb 15, 2024 | Mar 12, 2024 |
| Credit of Share (Tentative) | Feb 15, 2024 | Mar 12, 2024 |
| Listing date (Tentative) | Feb 16, 2024 | Mar 13, 2024 |
| Anchor Lockin End date 1 | Mar 15, 2024 | Apr 10, 2024 |
| Anchor Lockin End date 2 | May 14, 2024 | Jun 09, 2024 |
Entero Healthcare Solutions IPO P/E ratio is 0, as compared to J.G.Chemicals IPO P/E ratio of 16.25.
| Entero Healthcare Solutions IPO | J.G.Chemicals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 77.11 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 52.43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 0 | 16.25 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹3021.21 Cr. | ₹866.01 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | -2.66% | 8.20% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 6.06% | 11.86 % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.45 | 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.00 | ₹13.60 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -1.86% | 8.16% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Entero Healthcare Solutions IPO Retail Individual Investors (RII) are offered 12,65,500 shares while in J.G.Chemicals IPO retail investors are offered 12,65,500 shares. Qualified Institutional Buyers (QIB) are offered 37,96,503 shares in Entero Healthcare Solutions IPO and 22,73,212 shares in J.G.Chemicals IPO.
| Entero Healthcare Solutions IPO | J.G.Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | 56,94,753 shares | 34,09,818 shares |
| Market Maker Reservation | ||
| QIB | 37,96,503 shares | 22,73,212 shares |
| NII | 18,98,251 shares | 17,04,910 shares |
| RII | 12,65,500 shares | 39,78,123 shares |
| Employee | 70,237 shares | |
| Others | ||
| Total | 1,27,25,244 shares | 1,13,66,063 shares |
Entero Healthcare Solutions IPO subscribed 1.53x in total, whereas J.G.Chemicals IPO subscribed 28.52x.
| Entero Healthcare Solutions IPO | J.G.Chemicals IPO | |
|---|---|---|
| QIB (times) | 2.28x | 32.33x |
| NII (times) | 0.22x | 47.92x |
| Big NII (times) | 0.16x | 50.26x |
| Small NII (times) | 0.33x | 43.24x |
| RII (times) | 1.33x | 18.03x |
| Employee (times) | 1.25x | |
| Other (times) | ||
| Total (times) | 1.53x | 28.52x |
